ACETAMINOPHEN TABLET EXTENDED RELEASE and PYREXIA

13,941 reports of this reaction

1.9% of all ACETAMINOPHEN TABLET EXTENDED RELEASE reports

#10 most reported adverse reaction

Overview

PYREXIA is the #10 most commonly reported adverse reaction for ACETAMINOPHEN TABLET EXTENDED RELEASE, manufactured by AAA Pharmaceutical, Inc.. There are 13,941 FDA adverse event reports linking ACETAMINOPHEN TABLET EXTENDED RELEASE to PYREXIA. This represents approximately 1.9% of all 733,850 adverse event reports for this drug.

Patients taking ACETAMINOPHEN TABLET EXTENDED RELEASE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA13,941 of 733,850 reports

PYREXIA is a less commonly reported adverse event for ACETAMINOPHEN TABLET EXTENDED RELEASE, but still significant enough to appear in the safety profile.

Other Side Effects of ACETAMINOPHEN TABLET EXTENDED RELEASE

In addition to pyrexia, the following adverse reactions have been reported for ACETAMINOPHEN TABLET EXTENDED RELEASE:

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

ABACAVIR SULFATEACALABRUTINIBACETAMINOPHENACETAMINOPHEN 325MGACETAMINOPHEN 500MGACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATEACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HBRACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETYLCYSTEINEACYCLOVIRACYCLOVIR SODIUMADALIMUMAB

Frequently Asked Questions

Does ACETAMINOPHEN TABLET EXTENDED RELEASE cause PYREXIA?

PYREXIA has been reported as an adverse event in 13,941 FDA reports for ACETAMINOPHEN TABLET EXTENDED RELEASE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with ACETAMINOPHEN TABLET EXTENDED RELEASE?

PYREXIA accounts for approximately 1.9% of all adverse event reports for ACETAMINOPHEN TABLET EXTENDED RELEASE, making it a notable side effect.

What should I do if I experience PYREXIA while taking ACETAMINOPHEN TABLET EXTENDED RELEASE?

If you experience pyrexia while taking ACETAMINOPHEN TABLET EXTENDED RELEASE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

ACETAMINOPHEN TABLET EXTENDED RELEASE Full ProfileAll Drugs Causing PYREXIAAAA Pharmaceutical, Inc. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.